What is Design Therapeutics, Inc.'s net change in cash?

Design Therapeutics, Inc. (DSGN) reported net change in cash of -$4.09M in Q1 2026.

How has Design Therapeutics, Inc.'s net change in cash changed year-over-year?

Design Therapeutics, Inc.'s net change in cash increased by 54.1% year-over-year, from -$8.9M to -$4.09M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Design Therapeutics, Inc. DSGN Net Change in Cash

Net Change in Cash at other companies

ALN

Alnylam PharmaceuticalsALNY

$53.61M0.0%

Intellia TherapeuticsNTLA

-$17.47M+68.0%

CRISPR TherapeuticsCRSP

$72.24M+215%

Dyne Therapeutics, Inc.DYN

-$140.25M-481%

Vor BiopharmaVOR

-$226.61M-610%

Taysha Gene Therapies, Inc.TSHA

-$43.19M-92.4%

Other financials

Income statement

See full

Revenue-—

Operating income-$19.7M+3.5%

Net income-$17.6M+0.4%

EPS (diluted)-$0.29+6.5%

Balance sheet

See full

Cash & equivalents$12.8M-6.6%

Total debt$2.7M+27.7%

Total equity$218.1M-4.3%

Total assets$230.4M-3.0%

Cash flow

See full

Operating cash flow-$16.4M+2.1%

CapEx--100%

Free cash flow-$16.4M+2.6%

Valuation

See full

Market cap$860.66M+295%

Enterprise value$850.62M+313%

Profitability

See full

Operating margin-3,685.8%—

Net margin-3,663.7%—

Returns & leverage

See full

Return on equity-31.3%+19.5pp

Debt / equity0×0.0×

Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Design Therapeutics, Inc.'s net change in cash?: Design Therapeutics, Inc. (DSGN) reported net change in cash of -$4.09M in Q1 2026.
How has Design Therapeutics, Inc.'s net change in cash changed year-over-year?: Design Therapeutics, Inc.'s net change in cash increased by 54.1% year-over-year, from -$8.9M to -$4.09M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.